Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Journal of Molecular Neuroscience : MN|December 4, 2003
Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's diseasePeter Klivenyi, Gabrielle Gardian, Noel Y Calingasan, et al.Journal of Neurochemistry|January 15, 2004
Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosisPeter Klivenyi, Mahmoud Kiaei, Gabrielle Gardian, et al.Journal of Neurochemistry|June 17, 2003
Increased survival and neuroprotective effects of BN82451 in a transgenic mouse model of Huntington's diseasePeter Klivenyi, Robert J Ferrante, Gabrielle Gardian, et al.Neuromolecular Medicine|June 23, 2005
Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicityPeter Klivenyi, Gabrielle Gardian, Noel Y Calingasan, et al.Neurobiology of Disease|November 22, 2005
Mice lacking alpha-synuclein are resistant to mitochondrial toxinsPeter Klivenyi, Donald Siwek, Gabrielle Gardian, et al.Journal of Neurochemistry|March 11, 2004
Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicityPeter Klivenyi, Anatoly A Starkov, Noel Y Calingasan, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 3, 2006
Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosisMahmoud Kiaei, Susanne Petri, Khatuna Kipiani, et al.Pageof 1